glp 1 discontinuation Patients with diabetes who remained on GLP-1 drugs had lower cardiovascular risk 🔬 GLP-1/GIP Therapy Discontinuation: Why

In short, the research showed that patients with type 2 diabetes or who were overweight/obese and taking GLP-1 receptor agonists were at a higher risk of developing NAION

The passage of GLP1 agonists across the bloodbrain barrier is incompletely understood, but it has been suggested that it might involve GLP1 receptordependent ligand uptake and transcytosis across tanycytes (Gabery et al., 2020), the choroid plexus (Botfield et al., 2017), or endothelial cells (Fu et al., 2020), that act as conduits between the peripheral circulation and the brain

Some studies have shown that differences in the expression of GLP-1R on the surface of different pancreatic cells may affact the development of pancreatic cancer

In anticipation of Retatrutide's availability, it's valuable to understand how to get Retatrutide once it's on the market

is supported by a postdoctoral fellowship provided by the Japan Society for the Promotion of Science.

Alpha-linolenic acid (ALA) and docosahexaenoic acid (DHA), polyunsaturated omega-3 fatty acids found in flaxseed oil and fish, also increase GLP-1 and lower blood sugar